- Home
- VOR vs LNSR Comparison
VOR vs LNSR Comparison
Compare VOR & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- LNSR
- Stock Information
- Founded
- VOR 2015
- LNSR 2004
- Country
- VOR United States
- LNSR United States
- Employees
- VOR N/A
- LNSR N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- LNSR Medical Electronics
- Sector
- VOR Health Care
- LNSR Health Care
- Exchange
- VOR Nasdaq
- LNSR Nasdaq
- Market Cap
- VOR 57.1M
- LNSR 63.4M
- IPO Year
- VOR 2021
- LNSR N/A
- Fundamental
- Price
- VOR $0.87
- LNSR $7.70
- Analyst Decision
- VOR Strong Buy
- LNSR
- Analyst Count
- VOR 7
- LNSR 0
- Target Price
- VOR $11.36
- LNSR N/A
- AVG Volume (30 Days)
- VOR 577.8K
- LNSR 43.0K
- Earning Date
- VOR 11-07-2024
- LNSR 11-07-2024
- Dividend Yield
- VOR N/A
- LNSR N/A
- EPS Growth
- VOR N/A
- LNSR N/A
- EPS
- VOR N/A
- LNSR N/A
- Revenue
- VOR N/A
- LNSR $48,868,000.00
- Revenue This Year
- VOR N/A
- LNSR $25.07
- Revenue Next Year
- VOR N/A
- LNSR $24.95
- P/E Ratio
- VOR N/A
- LNSR N/A
- Revenue Growth
- VOR N/A
- LNSR 21.29
- 52 Week Low
- VOR $0.63
- LNSR $2.67
- 52 Week High
- VOR $3.14
- LNSR $8.17
- Technical
- Relative Strength Index (RSI)
- VOR 47.17
- LNSR 57.25
- Support Level
- VOR $0.83
- LNSR $7.33
- Resistance Level
- VOR $1.10
- LNSR $7.98
- Average True Range (ATR)
- VOR 0.10
- LNSR 0.51
- MACD
- VOR -0.01
- LNSR -0.07
- Stochastic Oscillator
- VOR 22.43
- LNSR 63.33
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.